BioMatrix SpRx

Weston, United States Founded: 2001 • Age: 25 yrs Acquired By Frazier Healthcare Partners
Specialty pharmacy services and digital health solutions are provided nationwide.
Annual revenue - Latest available
Total funding - 2 rounds
Employees 373 Tracked headcount
Investors 4 Known backers
Products 4 Services tracked
Competitors 5 Brand Intelligence

About BioMatrix SpRx

BioMatrix SpRx is a company based in Weston (United States) founded in 2001 was acquired by Frazier Healthcare Partners in August 2024. The company has 373 employees as of December 31, 2022. BioMatrix SpRx has completed 4 acquisitions, including City Drugs, Decillion Healthcare and Elwyn Pharmacy Group. BioMatrix SpRx offers products and services including Immunoglobulin (IG), Transplant, Bleeding Disorders, and Biologics / Biosimilars. BioMatrix SpRx operates in a competitive market with competitors including Pheno, Fideliomed, Joint Scanner and SCD Warrior, among others.

  • Headquarter Weston, United States
  • Employees 373 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Biomatrix Specialty Pharmacy, Llc
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BioMatrix SpRx

BioMatrix SpRx offers a comprehensive portfolio of products and services, including Immunoglobulin (IG), Transplant, Bleeding Disorders, and Biologics / Biosimilars.

Product name locked
Category locked
Primary

Treatment for immune system disorders and related conditions

Product name locked
Category locked
Locked

Support for organ transplant patients and recovery processes

Product name locked
Category locked
Locked

Therapy for managing blood clotting and related issues

Product name locked
Category locked
Locked

Medications for various chronic and immune-related diseases

People of BioMatrix SpRx

Headcount 200-500
Employee Profiles 35
Employee Profiles
People
Aaron Morrison
Territory Account Executive-neurology & Immunology, Az/nv/ut
People
Ken Trader
Vice President, Managed Markets
People
Craig Och
Regional Account Manager In Neurology, Immunology & Transplant
People
Gregori Romenski
Regional Account Manager

Unlock access to complete

Funding Insights of BioMatrix SpRx

Investors in BioMatrix SpRx

BioMatrix SpRx has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners, LBC Credit Partners and ACON Investments.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investment firm based out of USA
Locked Locked Locked
-
Locked Locked Locked
Triton Pacific is engaged in equity investments for growth companies.
Locked Locked Locked
Premium access

Investor details for BioMatrix SpRx

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioMatrix SpRx

BioMatrix SpRx has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include City Drugs, Decillion Healthcare and Elwyn Pharmacy Group.

Investments
Premium access

Investment portfolio details for BioMatrix SpRx

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Critical and chronic healthcare services are provided to patients.
Locked Locked 2013 Locked
Pharmaceutical products are distributed by City Drugs in the market.
Locked Locked 2011 Locked
Provider of medication therapy and infusion services
Locked Locked 2008 Locked
Premium access

Complete acquisition details for BioMatrix SpRx

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - BioMatrix SpRx

Premium access

Detailed financials for BioMatrix SpRx

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biomatrix Sprx Comparisons

BioMatrix SpRx Primary company
Description
Specialty pharmacy services and digital health solutions are...
Location
Weston, United States
Founded Year
2001
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
373
As of 2022
Premium access

Peer comparison for BioMatrix SpRx

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioMatrix SpRx

BioMatrix SpRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pheno, Fideliomed, Joint Scanner and SCD Warrior, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Develops AI-based blood testing technology for wellness and risk assessment.
Locked Locked Locked
Provides digital platform for real-time diagnosis of health conditions in primary care settings.
Locked Locked Locked
Delivers specialized therapy plan solutions for hemophilia patients.
Locked Locked Locked
Offers an application for tracking and monitoring symptoms of sickle cell anemia.
Premium access

Detailed competitors of BioMatrix SpRx

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biomatrix Sprx

Premium access

Complete news archive for BioMatrix SpRx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioMatrix SpRx

BioMatrix SpRx was founded in 2001 and raised its 1st funding round 16 years after it was founded.

BioMatrix SpRx is headquartered in Weston, United States. It is registered at Weston, Florida, United States.

As of Dec 31, 2022, the latest employee count at BioMatrix SpRx is 373.

BioMatrix SpRx provides nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Its products include BiologicTx MatchGrid, a proprietary HIPAA compliant software application that provides doctors and clinicians with the tools necessary to match living organs with patients who are willing, healthy, but incompatible donors. It also offers BiologicTx Sequence that combines drug therapy interventions with a patients medical history to provide an overview of therapeutic impact and treatment efficacy. It offers bleeding disorder program that results in less frequent bleeding episodes, reduced number of infusions, and fewer emergency room visits. Claims that the BioMatrix Family of Companies is awarded various specialty pharmacy accreditations, including ACHC accreditation in all locations and URAC accreditations in our Camarillo, CA, and Totowa, NJ locations.

BioMatrix SpRx's top competitors include Pheno, Fideliomed and Joint Scanner.

BioMatrix SpRx offers Immunoglobulin (IG), Transplant, Bleeding Disorders, and Biologics / Biosimilars.

BioMatrix SpRx has made 4 acquisitions, including City Drugs, Decillion Healthcare, and Elwyn Pharmacy Group.

BioMatrix SpRx has 4 investors. Key investors include Frazier Healthcare Partners, LBC Credit Partners, ACON Investments, and Triton Pacific.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available